ConductScience.org, home

Library / Trial comparisons

Active Vitamin E vs Vitamin E Placebo: Effect of Vitamin E on CRA Occurrence, Analyzed by Active Vitamin E vs. Vitamin E Placebo

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.3550.3380.371wilsonClinicalTrials.gov
Risk in group 20.3440.3280.36wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.0106-0.01250.0337newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.030.9651.1logClinicalTrials.gov
Odds ratio, group 1 over group 21.050.9471.16logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Active Vitamin E than on Vitamin E Placebo94.1from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Active Vitamin EActive vitamin E +/- selenium1,1593,269OG000ClinicalTrials.gov
Group 2Vitamin E PlaceboVitamin E placebo +/- selenium1,1273,277OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleEffect of Vitamin E on CRA Occurrence, Analyzed by Active Vitamin E vs. Vitamin E PlaceboClinicalTrials.gov
DescriptionClinicalTrials.gov
Time frameFrom 1 year post randomization through study completionClinicalTrials.gov
PopulationMarginal analyses were performed, with arms pooled based on active vs. placebo Vitamin E.ClinicalTrials.gov

Trial 8

FieldValueSource
TitleS0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000ClinicalTrials.gov
NCT numberNCT00706121ClinicalTrials.gov
PhasesPHASE3ClinicalTrials.gov
ConditionsColorectal Cancer, Precancerous ConditionClinicalTrials.gov
InterventionsVitamin E, Selenium, Vitamin E placebo, selenium placeboClinicalTrials.gov
Lead sponsorSWOG Cancer Research NetworkClinicalTrials.gov
Results first posted2017-04-04ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT00706121?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.